Risk factors for bone metastasis in completely resected non-small-cell lung cancer

Future Oncol. 2017 Apr;13(8):695-704. doi: 10.2217/fon-2016-0237. Epub 2016 Nov 21.

Abstract

Aim: We assessed risk factors for bone metastasis in patients with completely resected non-small-cell lung cancer (NSCLC).

Materials & methods: A total of 374 NSCLC patients who had undergone a complete resection from January 2008 to May 2012 were included in this retrospective study. The Kaplan-Meier method and multivariate Cox regression analysis were used to evaluate risk factors for bone metastasis.

Results: A total of 47 (47/374; 12.6%) patients developed bone metastasis up until the last follow-up time. The patients with bone metastasis included 33 adenocarcinoma patients and 6 (4.9%) squamous cell carcinoma patients (p = 0.001). There were 17 (10.2%) patients with pathological stage (P-stage) I disease, 9 (9.5%) patients with P-stage II disease and 21 (18.8%) patients with P-stage III disease (p = 0.007) among all the bone metastasis patients. For patients without or with bone metastasis, the overall survival ratio at 3 years was 71.6% compared with 46.8% (p < 0.0001), respectively.

Conclusion: Adenocarcinoma and P-stage III disease were related to a high risk of bone metastasis.

Keywords: bone metastasis; non-small-cell lung cancer; risk factors.

MeSH terms

  • Adult
  • Aged
  • Bone Neoplasms / epidemiology*
  • Bone Neoplasms / mortality
  • Bone Neoplasms / secondary*
  • Carcinoma, Non-Small-Cell Lung / epidemiology
  • Carcinoma, Non-Small-Cell Lung / mortality
  • Carcinoma, Non-Small-Cell Lung / pathology*
  • Carcinoma, Non-Small-Cell Lung / surgery
  • Female
  • Humans
  • Lung Neoplasms / epidemiology
  • Lung Neoplasms / mortality
  • Lung Neoplasms / pathology*
  • Lung Neoplasms / surgery
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Pneumonectomy / methods
  • Prognosis
  • Retrospective Studies
  • Risk Factors
  • Survival Analysis